Micafungin in Inflamed Human Eyes

4 Kiyofumi Mochizuki, MD, PhD, Akira Sawada, MD, PhD, Shinsuke Suemori, MD, PhD, 5 Hideaki Kawakami, MD, PhD, Yoshiaki Niwa, MD, PhD, Yuji Kondo, MD, PhD, Kiyofumi 6 Ohkusu, PhD, Noriaki Yamada, MD, Shinji Ogura, MD, PhD, Takashi Yaguchi, PhD, Kazuko 7 Nishimura, MD, PhD, Satoshi Kishino, PhD 8 9 Department of Ophthalmology, Gifu University Graduate School of Medicine, Gifu 10 Department of Ophthalmology, Gifu Municipal Hospital, Gifu 11 Department of Ophthalmology, Gifu Prefectural General Medical Center, Gifu 12 Department of Ophthalmology, Chuno Kosei Hospital, Seki 13 Department of Microbiology, Gifu University Graduate School of Medicine, Gifu 14 Department of Emergency & Disaster Medicine, Advanced Critical Care Center Gifu 15 University, Gifu 16 Medical Mycology Research Center, Chiba University, Chiba 17 Department of Microbiology, Dokkyo Medical University, Tochigi 18 Department of Medication Use Analysis and Clinical Research, Meiji Pharmaceutical 19 University, Tokyo 20 21 All correspondence to: Kiyofumi Mochizuki, MD, PhD, Gifu University Graduate School of 22 Medicine, 1-1 Yanagido, Gifu-shi 501-1194, Japan 23 Tel: +81-58-230-5287 Fax: +81-58-230-6289 24 E-mail: [email protected] 25 26 Word count for the abstract:75 27 Word count for the text: 1226 28 29 The authors have no proprietary or financial interest in any products used in this study. 30 None to declare 31 Copyright © 2013, American Society for Microbiology. All Rights Reserved. Antimicrob. Agents Chemother. doi:10.1128/AAC.02300-12 AAC Accepts, published online ahead of print on 20 May 2013